|
1）Serruys P, Morice M, Kappetein A, et al. Percutaneous coronary intervention versus coronary-artery bypass grafting for severe coronary artery disease. N Engl J Med. 2009; 360: 961-72
|
|
|
|
2）Mohr FW, Morice M-C, Kappetein AP, et al. Coronary artery bypass graft surgery versus percutaneous coronary intervention in patients with three-vessel disease and left main coronary disease: 5-year follow-up of the randomised, clinical syntax trial. Lancet. 2013; 381: 629-38
|
|
|
|
|
|
3）虚血性心疾患に対するバイパスグラフトと手術術式の選択ガイドライン（2011年改訂版）http://www.j-circ.or.jp/guideline/pdf/JCS2011_ochi_h.pdf
|
|
|
|
|
|
4）安定冠動脈疾患における待機的PCIのガイドライン（2011年改訂版）http://www.j-circ.or.jp/guideline/pdf/JCS2011_fujiwara_h.pdf
|
|
|
|
|
|
5）Kappetein AP, Feldman TE, Mack MJ, et al. Comparison of coronary bypass surgery with drug-eluting stenting for the treatment of left main and/or three-vessel disease: 3-year follow-up of the syntax trial. Eur Heart J. 2011; 32: 2125-34
|
|
|
|
|
|
6）Capodanno D, Tamburino C. Unraveling the EXCEL: promises and challenges of the next trial of left main percutaneous coronary intervention. Int J Cardiol. 2012; 156: 1-3
|
|
|
|
|
|
7）Park SJ, Kim YH, Park DW, et al. Randomized trial of stents versus bypass surgery for left main coronary artery disease. N Engl J Med. 2011; 364: 1718-27
|
|
|
|
|
|
8）Seung KB, Park DW, Kim YH, et al. Stents versus coronary-artery bypass grafting for left main coronary artery disease. N Engl J Med. 2008; 358: 1781-92
|
|
|
|
|
|
9）Park DW, Seung KB, Kim YH, et al. Long-term safety and efficacy of stenting versus coronary artery bypass grafting for unprotected left main coronary artery disease: 5-year results from the MAIN-COMPARE (Revascularization for Unprotected Left Main Coronary Artery Stenosis: Comparison of Percutaneous Coronary Angioplasty Versus Surgical Revascularization) registry. J Am Coll Cardiol. 2010; 56: 117-24
|
|
|
|
|
|
10）Park DW, Kim YH, Yun SC, et al. Complexity of atherosclerotic coronary artery disease and long-term outcomes in patients with unprotected left main disease treated with drug-eluting stents or coronary artery bypass grafting. J Am Coll Cardiol. 2011; 57: 2152-9
|
|
|
|
|
|
11）Kimura T, Morimoto T, Furukawa Y, et al. Long-term outcomes of coronary-artery bypass graft surgery versus percutaneous coronary intervention for multivessel coronary artery disease in the bare-metal stent era. Circulation. 2008; 118: S199-209
|
|
|
|
|
|
12）Kimura T, Morimoto T, Furukawa Y, et al. Long-term safety and efficacy of sirolimus-eluting stents versus bare-metal stents in real world clinical practice in Japan. Cardiovasc Interv Ther. 2011; 26: 234-45
|
|
|
|
|
13）Shiomi H, Morimoto T, Hayano M, et al; CREDO-Kyoto PCI/CABG Registry Cohort-2 Investigators. Comparison of long-term outcome after percutaneous coronary intervention versus coronary artery bypass grafting in patients with unprotected left main coronary artery disease (from the CREDO-Kyoto PCI/CABG Registry Cohort-2). Am J Cardiol. 2012; 110: 924-32
|
|
|
|
|
|
14）Serruys PW, Ong ATL, van Herwerden LA, et al. Five-year outcomes after coronary stenting versus bypass surgery for the treatment of multivessel disease - the final analysis of the arterial revascularization therapies study (arts) randomized trial. J Am Coll Cardiol. 2005; 46: 575-81
|
|
|
|
|
|
15）Hueb W, Lopes NH, Gersh BJ, et al. Five-year follow-up of the medicine, angioplasty, or surgery study (mass ii): A randomized controlled clinical trial of 3 therapeutic strategies for multivessel coronary artery disease. Circulation. 2007; 115: 1082-9
|
|
|
|
|
|
16）BARI 2D Study Group, Frye RL, August P, et al. A randomized trial of therapies for type 2 diabetes and coronary artery disease. N Engl J Med. 2009; 360: 2503-15
|
|
|
|
|
|
17）Kapur A, Hall RJ, Malik IS, et al. Randomized comparison of percutaneous coronary intervention with coronary artery bypass grafting in diabetic patients. 1-year results of the cardia (coronary artery revascularization in diabetes) trial. J Am Coll Cardiol. 2010; 55: 432-40
|
|
|
|
|
|
18）Farkouh ME, Domanski M, Sleeper LA, et al; FREEDOM Trial Investigators. Strategies for multivessel revascularization in patients with diabetes. N Engl J Med. 2012; 367: 2375-84
|
|
|
|
|
|
19）Weintraub WS, Grau-Sepulveda MV, Weiss JM, et al. Comparative effectiveness of revascularization strategies. N Engl J Med. 2012; 366: 1467-76
|
|
|
|
|
|
20）Hlatky MA, Boothroyd DB, Baker L, et al. Comparative effectiveness of multivessel coronary bypass surgery and multivessel percutaneous coronary intervention a cohort study. Ann Intern Med. 2013; 158: 727-34
|
|
|
|
|
|
21）Tazaki J, Shiomi H, Morimoto T, et al. Three-year outcome after percutaneous coronary intervention and coronary artery bypass grafting in patients with triple-vessel coronary artery disease: observations from the CREDO-Kyoto PCI/CABG Registry cohort-2. EuroIntervention. 2013; 9: 437-45
|
|
|
|
|
|
22）Roques F, Michel P, Goldstone AR, et al. The logistic EuroSCORE. Eur Heart J. 2003; 24: 881-2
|
|
|
|
|
|
23）Farooq V, van Klaveren D, Steyerberg EW, et al. Anatomical and clinical characteristics to guide decision making between coronary artery bypass surgery and percutaneous coronary intervention for individual patients: development and validation of SYNTAX score II. Lancet. 2013; 381: 639-50
|
|
|
|
|
|
24）Tanaka S, Sakata R, Marui A, et al; CRED-Kyoto Investigators. Predicting long-term mortality after first coronary revascularization: —the Kyoto model—. Circ J. 2012; 76: 328-34
|
|
|
|
|
25）Kyoto model https://sites.google.com/site/shirostatistics/prediction/kyoto-model
|
|
|
|
|